Getinge postpones 27 May Capital Markets Day and reschedules for a later date to be announced

| Source: Getinge AB
Getinge announced today that it is rescheduling its Capital Markets Day for a
later date to be announced. This decision was made based on very recent
communications with the U.S. Food & Drug Administration (FDA), which are the
subject of active discussions.

Getinge Group will hold its Capital Markets Day when it has more to report about
these discussions, their potential financial impact on the company, and the
latest progress being made in strengthening Medical Systems’ quality management

Getinge apologizes to those who had made plans to attend the Capital Markets Day
and are inconvenienced by the rescheduling.

As announced earlier, the Medical Systems business area has been in a dialogue
with the FDA to ensure that efforts made to strengthen its quality management
system fully meet the FDA’s requirements based on a series of inspections that
took place last year. The enhancements at Medical Systems are well under way and
are expected to be completed during the second half of 2015, and, as previously
disclosed, costs for these efforts are expected to amount to approximately SEK
800 million and were charged to the first quarter results of 2014.

This announcement will be followed by a conference call at 10.00 AM CET
tomorrow, hosted by Johan Malmquist, CEO Getinge Group and Ulf Grunander, CFO
Getinge Group.

Conference Call

To participate, please call:

Sweden: +46 (0)8 5853 6965

UK: +44 (0)20 3427 1914

US: +1 646 254 3361

Passcode: 6903282


09.45 Call the conference number

10.00 Introduction

10.10 Q&A

11.00 End of conference

A recorded version of the conference will be accessible for five working days at
the following number:

Sweden: +46 (0)8 5051 3897

UK: +44 (0)20 3427 0598

US: +1 347 366 95 65

Passcode: 6903282

The Getinge Group is a global leading medical technology company that operates
in the areas of surgery, intensive care, infection control, care ergonomics and
wound care. The Group is divided into three business areas: Medical Systems,
Extended Care and Infection Control and operates under the brands ArjoHuntleigh,
Getinge and Maquet.